State policy and action news

The American Academy of Dermatology Association (AADA) is constantly working with state dermatology societies and state legislatures to introduce, support, or oppose bills that could affect your practice. Use the links below to read AADA comments about issues that matter to you and your patients.

2015

California

AADA also sent a letter opposing SB 323, which would authorize independent practice for nurse practitioners. Read more here.

AADA sent a letter of support for AB 374, which would require insurers to maintain a process for exemption from step therapy protocols if a prescribing physician deems it medically inappropriate for the patient. Read the letter here.  

AADA sent a letter of support for CalDerm's legislation, AB 1464, which would place the regulation of indoor tanning devices under the Department of Public Health, alongside X-Ray machines and other radiologic materials. The bill also imposes a licensure fee on the owners of tanning facilities, requires indoor tanning device operators to receive training in the operation of tanning equipment, and would edit the existing Radiation Control Law to impose additional inspection requirements for indoor tanning devices. Read more here

CalDerm and AADA sent a joint letter opposing legislation which would authorize optometrists in California to perform scalpel surgeries on the eye. Read the letter here

AADA sent a letter supporting and providing recommendations for SB 137, legislation which would require health insurers to maintain accurate and up-to-date online directories of all in-network providers. Read the letter here

Connecticut

AADA sent a letter of support for legislation which would adopt the AMA and American College of Surgeons definition of surgery. Read the letter here

AADA, ASDSA,  the American Society for Laser Medicine and Surgery, and the Connecticut Dermatology and Dermatologic Surgery Society sent a joint letter opposing legislation in Connecticut that would allow electrologists to perform laser hair removal without physician supervision. Read the letter here

 

 

Florida

 

 

Georgia

AADA sent a letter of support for legislation in Georgia which would require health care providers to wear identification badges that clearly identify name and license or educational degree.  The bill passed committee and awaits a house floor vote. Read the letter here

 

Idaho

In 2014, the Idaho Board of Pharmacy proposed regulations to allow for the substitution of biosimilars without physician notification. In accordance with the proposal, pharmacists would be authorized to substitute biosimilars for biologic drugs without notifying the health care provider. The AADA opposes recently passed legislation in Idaho that would implement the BOP's proposal  and continues to advocate for a physician notification provision. 

Most recently, AADA sent a letter of support for legislation which would which require a pharmacist to communicate to a physician that an interchangeable biosimilar has been substituted.

 

Illinois

AADA and the Illinois Dermatological Society sent a joint letter of support for legislation which would allow for the dispensing of biosimilars.  The letter calls for an amending of the physician notification language to notification by the time of dispensing. Read the letter here

Indiana

AADA sent a letter of support for SB 492, legislation which would strengthen truth in advertising laws by requiring that all provider advertisements identify the type of professional license and board certification. The included a recommendation for an amendment that would allow the term “board-certified” be used in provider advertising only if materials include the full name of the certifying board member board of the American Board of Medical Specialties (ABMS) or the American Osteopathic Association (AOA), or has received graduate training by an approve accreditation body. The amendment was accepted. Read the letter here

Iowa

 AADA sent two letters of support for legislation which would restrict minors under the age of 18 from using indoor tanning devices in Iowa. Read one of the letters here

 

 

Kentucky

AADA support legislation to prevent minors under 18 from using indoor tanning beds in Kentucky. Read the letter here

 

Maryland

AADA sent a letter of support for HB 56, legislation which would restrict minors under the age of 18 from using indoor tanning devices in a tanning facility. Several AADA members testified in favor of the legislation. Read the letter here

The Maryland legislature has also been considering legislation to authorize the dispensing of biosimilars.  AADA support bills in both chambers of the legislature, but has requested a friendly amendment to alter the physician communication time frame to "by the time of dispensing," as stated in the AADA position statement.  Read the letters here and here

Maine

AADA sent a joint letter with Maine Medical Association, AMA, and eight other specialties urging the Maine Joint Committee on Appropriations and Financial Affairs to remove the tax on cosmetic medical procedures from the proposed 2016-2017 budget. Read the letter here


 

 

 

 

Minnesota

AADA sent a letter of support for SF 253, legislation which would adopt the Interstate Medical Licensure Compact.  The Compact would provide physicians greater flexibility to practice across state lines while promoting patient safety, high-quality care, and increased patient access to dermatologists in Minnesota.  Read the letter here.

 

 

 

 

Montana

AADA sent a letter of support for SB 125, legislation which would prevent minors from using indoor tanning devices.  Read the letter of support here. The Montana has also been reviewing a competing parental consent bill, SB 130. 

AADA submitted comments to the Montana Insurance Commissioner concerning draft network adequacy regulations.  The comments included six recommendations; read more here.

 

 

Nebraska

AADA sent a letter of support for legislation which would require individuals licensed under the Uniform Credentialing Act to clearly identify in any advertisement for their health care services the type of credential held. Additionally, LB 452 would prohibit any false or misleading advertising of one’s credentials. Read the letter here.

AADA recently opposed legislation in Nebraska which would authorize nurse practitioners to practice independently.  Read the letter here

 

 

 

 

 

 

 

New Jersey

AADA and the Dermatological Society of New Jersey sent a joint letter of support for legislation that would authorize the dispensing and substitution of biosimilars.  The letter asked for a friendly amendment to the physician notification language, asking that it be amended to notification by the time of dispensing. Read the letter here

 

 

 

 

Nevada

AADA sent a letter of support for SB 251, legislation which would adopt the Interstate Medical Licensure Compact.  The Compact would provide physicians greater flexibility to practice across state lines while promoting patient safety, high-quality care, and increased patient access to dermatologists in Nevada.  Read the letter here.

AADA sent a letter detailing recommendations for draft regulations on network adequacy. Read the letter here

 

 

New Hampshire

 AADA sent a letter of support for HB 136, legislation which would prevent minors from using indoor tanning devices.  Read the letter here

New York

The AADA and the New York State Society of Dermatology and Dermatologic Surgery sent a joint letter of support for two companion bills that would provide physicians with a transparent process to appeal step therapy for patients needing a particular treatment.  aimed at ensuring patients will not have to wait for the medication that their doctors have prescribed as a result. Additionally, the bills would require clinical review criteria for establishing step therapy protocols be based on clinical practice guidelines that are developed and endorsed by an independent, multidisciplinary panel of experts and is based on high quality studies, research and medical practice.  Read the letter here

 

AADA sent a letter of support for S.4651-A, legislation that would require health care providers to wear photo identification badges that clearly display one’s name and the license held.  Read the letter here

North Carolina

Governor McCrory signed HB 158, legislation to prohibit minors under 18 from using indoor tanning beds.  AADA sent an action alert and a letter to the governor urging his signature. Read the letter here

 

 

 

Oregon

AADA sent a letter of support for legislation in Oregon which would authorize the dispensing of biosimilars.  In the letter, AADA requested a friendly amendment to alter the physician communication time frame to "by the time of dispensing," as stated in the AADA position statement.  Read the letter here.  

AADA joined eight organizations, including the Oregon Dermatology Society and the American Society for Dermatologic Surgery Association in sending a letter urging the Oregon legislature's Joint Committee on Ways and Means to amend HB 2642, which would would allow estheticians to perform procedures using lasers.  Read the letter here

 

Pennsylvania

AADA sent a joint letter with the Pennsylvania Academy of Dermatology and Dermatologic Surgery to the Pennsylvania Senate President, Lieutenant Governor Stack, in support of SB 514. In the letter, AADA and PAD seek  a friendly amendment that would require a pharmacist to communicate the substitution of an interchangeable biological product to the prescriber by the time of dispensing, in accordance with our position statement. Read more here

AADA sent a letter of support for HB 1282, the “Health Care Professional Transparency Act,”which would require all health care practitioners should identify or disclose their degree or field of study, board-certification (if any) and licensure to each patient.  Read the letter here

Rhode Island

AADA sent a letter of support for legislation in Rhode Island which would require insurers to maintain accurate directories of in-network providers.  Read the letter here

 

 

Tennessee

AADA sent a letter of support for legislation in Tennessee that would authorize the dispensing of biosimilars.  AADA included a recommendation for an amendment to ensure physicians are notified of the dispensed biosimilar by the time of dispensing, as stated in the AADA Position Statement on Generic Therapeutic and Biosimilar Substitution. 

 

 

Washington

 AADA submitted a letter containing recommendations for the second phase of draft regulations on network adequacy.  Read the letter here

 



 

Additional resources

media toolkit rv

Media relations toolkit

Information on a variety of dermatologic issues that have recently been in the news.

 Leg conference rr

Legislative Conference

Learn about the AADA event held annually in Washington, D.C.

leadership institute

Leadership Institute programs

A variety of programs to develop specialty leaders.

mentor_rr.jpg
 

Mentoring

Learn about AAD mentoring/mentee opportunities
volunteer_rr.jpg 

Volunteering

Help patients, communities, and the profession.

 

SkinPAC_logo_100.png

SkinPAC

Support advocacy efforts through SkinPac.

DAN_logo_100.png

Take action!

Contact legislators through the Dermatology Advocacy Network